A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia
Article
Rohrmeier, C., Sachs, H. G. and Kuehnel, T. S. (2012) A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia. European Archives of Oto-Rhino-Laryngology 269 (2), pp. 531-536.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Archives of Oto-Rhino-Laryngology | ||||
| Publisher | SPRINGER | ||||
| Place of Publication | NEW YORK | ||||
| Volume | 269 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | pp. 531-536 | ||||
| Date | 2012 | ||||
| Date of publication | 19 Dec 2024 09:43 | ||||
| Institutions | Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde | ||||
| Identification Number |
| ||||
| Keywords | ENDOTHELIAL GROWTH-FACTOR; CLINICAL-TRIAL; HHT PATIENTS; FACTOR VEGF; EPISTAXIS; THERAPY; MANIFESTATIONS; EXPRESSION; MANAGEMENT; SEVERITY; Bevacizumab; Avastin; Hereditary haemorrhagic telangiectasia (HHT); Epistaxis; VEGF; Retrospective | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 64107 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric